Sunitinib malate CAS:341031-54-7

• Post Date:

  Jun 26,2015

• Expiry Date:

  Dec 23,2015

• Detailed Description:

  Cas No. :341031-54-7 Quantity: 1000Kilograms
  Specs:Pharmacuetical raw materials intermediate ste
  Price:1 USD FCL
  Payment Method: Bank transfer, Western Union, Money Gram, Ban
  Here at Hubei Yuancheng Saichuang Technology Co.Ltd .we are one of the worlds leading manufactures of Anabolic Steroids and Ancillary pharmaceuticals for over 15 years. Specializing in "safety, efficiency, Security" service .Get the service and products your desire here. please contact me through c03 at yccreate.com
  
  Sunitinib malate
  
  Chinese alias:N- (2- (two ethyl amino) ethyl) -5- ((Z) - (5- -1,2- two -2- fluoride hydrogen oxygen generation -3H- indole -3- subunit) methyl) -2,4- two methyl -1H- pyrrole -3- formamide (2S) - hydroxy acid salt; sunitinib malate; sunitinib malate
  
  English name:N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
  
  CAS:341031-54-7
  
  The molecular formula:C22H27FN4O2.C4H6O5
  
  Molecular weight:532.566
  
  Appearance:Red powder
  
  
  Melting point:189℃～191℃
  
  Assay:99%
  
  Packing:1kg aluminum foil bag or packaged according to customer requirements
  
  Use:Sunitinib malate by preventing cancer cells of blood and nutrients needed for growth play a role in the treatment. Clinical trials show that the medicine, can delay the gastrointestinal stromal tumor growth speed, and can reduce the size of renal cell cancer. Sunitinib malate is the first to selectively target multiple tyrosine kinase receptor model targeting drugs, combined with the suspension to the anti angiogenic blood supply of tumor cells and tumor directly attack the tumor cell two mechanisms. It represents a new round of the advent of targeted therapies, which can directly attack the tumor toxicity, nor conventional chemotherapy.
  Min. Order:10/Gram
  Supply Ability:mass stock
  More information,lps contact:
  c03@yccreate.com
  

• CAS Registry Number:

  341031-54-7

• Synonyms:

  ;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate;

• Molecular Formula:

  C₂₈H₃₈N₄O₇

• Molecular Weight:

  542.62392

• Molecular Structure:

  

• Company:

  wuhan technology development co.,ltd     [ China ]        

• Contact:

  gloriacui

• Tel:

  027-50756026

• Fax:

  86-68886696874

• Email:

  ycgc913@yccreate.com